Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Evaluation of in silico tools and Chat-GPT in identifying the impact of missense variants of immune-related genes associated with immunotherapy outcomes for solid tumors

Version 1 : Received: 27 February 2024 / Approved: 25 March 2024 / Online: 26 March 2024 (02:45:01 CET)

How to cite: Choi, Y.; Jung, C.M.; Kang, G.; Jang, J.J.; Chae, L.; Kim, P.H.; Hermida de Viveiros, P. Evaluation of in silico tools and Chat-GPT in identifying the impact of missense variants of immune-related genes associated with immunotherapy outcomes for solid tumors. Preprints 2024, 2024031496. https://doi.org/10.20944/preprints202403.1496.v1 Choi, Y.; Jung, C.M.; Kang, G.; Jang, J.J.; Chae, L.; Kim, P.H.; Hermida de Viveiros, P. Evaluation of in silico tools and Chat-GPT in identifying the impact of missense variants of immune-related genes associated with immunotherapy outcomes for solid tumors. Preprints 2024, 2024031496. https://doi.org/10.20944/preprints202403.1496.v1

Abstract

Understanding clinical significance of variants of unknown significance (VUS) reported in next-generation sequencing (NGS) has become essential in cancer treatment. Our study examined six widely used in silico tools: PolyPhen-2, Align-GVGD, MutationTaster2, CADD, REVEL, and Chat-GPT. We utilized a dataset of gene variants known to potentially affect immune therapy. No single tool could comprehensively determine mutation variant pathogenicity. MutationTaster2021 showed the highest overall accuracy and MCC among the tools. Notably, REVEL and Chat-GPT exhibited 100% specificity, suggesting their proficiency in accurately identifying pathogenic variants and minimizing false positives. In contrast, CADD displayed optimal sensitivity, making it suitable for effectively ruling out benign variants.

Keywords

solid tumor; Artificial intelligence; Variant classification; Pathogenicity; Variants of uncertain significance

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.